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Abstract:  Antinociceptive and anti-inflammatory activities of the ethanol extract from 
Annona muricata L. leaves were investigated in animal models. The extract delivered per 
oral route (p.o.) reduced the number of abdominal contortions by 14.42% (at a dose of  
200 mg/kg) and 41.41% (400 mg/kg). Doses of 200 and 400 mg/kg (p.o) inhibited both 
phases of the time paw licking: first phase (23.67% and 45.02%) and the second phase 
(30.09% and 50.02%), respectively. The extract (p.o.) increased the reaction time on a hot 
plate at doses of 200 (30.77% and 37.04%) and 400 mg/kg (82.61% and 96.30%) after 60 
and 90 minutes of treatment, respectively. The paw edema was reduced by the ethanol 
extract (p.o.) at doses of 200 (23.16% and 29.33%) and 400 mg/kg (29.50% and 37.33%) 
after 3 to 4 h of application of carrageenan, respectively. Doses of 200 and 400 mg/kg (p.o.), 
administered 4 h before the carrageenan injection, reduced the exudate volume (29.25 and 
45.74%) and leukocyte migration (18.19 and 27.95%) significantly. These results suggest 
that  A. muricata can be an active source of substances with antinociceptive and anti-
inflammatory activities. 
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1. Introduction 
Annona muricata L. (Annonaceae), commonly known as soursop, is found from Central America to 
South America, including the North, Northeast and Southeast regions of Brazil [1,2]. Traditionally, the 
leaves are used for headaches, insomnia, cystitis, liver problems, diabetes, hypertension and as an anti-
inflammatory, antispasmodic and antidysenteric [1,2]. The decoction of the leaves have parasiticide, 
antirheumatic and antineuralgic effects when used internally, while the cooked leaves, applied 
topically, fight rheumatism and abscesses [1-3]. 
Among the chemical constituents found in A. muricata, the alkaloids (reticulin, coreximine, 
coclarine and anomurine) [4,5] and essential oils (-caryophyllene,  -cadinene, epi-α-cadinol and   
-cadinol) [6,7] stand out. However, species of the Annonaceae family, including A. muricata, have 
also been targeted for investigation due to appurtenant substances in the acetogenins class [8] that have 
been isolated from different parts of the plant [9]. For example, annomuricins A and B, gigantetrocin 
A, annonacin-10-one, muricatetrocins A and B, annonacin, goniothalamicin [10], muricatocins A and 
B, annonacin A, (2,4-trans)-isoannonacin, (2,4-cis)-isoannonacin [11], annomuricin C, muricatocin C, 
gigantetronenin [12], annomutacin, (2,4-trans)-10R-annonacin-A-one, (2,4-cis)-10R-annonacin-A-one 
[13], annopentocins A, B and C, cis- and trans-annomuricin-D-ones [14], annomuricine, 
muricapentocin [15], muricoreacin and murihexocin C [16] and annocatacin A and B [17] were 
identified in the leaves. These acetogenins have cytotoxic properties against tumor cell lines [10-17] 
and molluscicidal activity [18]. In addition, A. muricata leaf extracts have antioxidant [19] and 
molluscicidal properties [20]. 
A. muricata ethnomedicinal use, especially for inflammation, rheumatism and neuralgy, still lacks 
scientifically supported pharmacological and clinical validation. In this sense, the aim of the present 
study was to investigate the antinociceptive and anti-inflammatory properties of the ethanol extract 
from A. muricata leaves using experimental animal models. 
2. Results and Discussion 
2.1. Acute Toxicity 
At the doses administered per oral route (p.o.), the ethanol extract from A. muricata leaves was 
toxic to animals with LD50 of 1.67 g/kg (95% confidence intervals 1.24-2.26 g/kg). This result served 
as a parameter for dosage definition in the experiments of antinociceptive and anti-inflammatory 
activities. Int. J. Mol. Sci. 2010, 11                 
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2.2. Writhing Response Induced by Acetic Acid in Mice 
Doses (p.o.) of 200 and 400 mg/kg of A. muricata extract significantly reduced (p < 0.01 and  
p < 0.001, respectively) the abdominal contortions induced by acetic acid to 57.87  1.55 s and   
39.62  1.97 s compared to the respective control (67.62  2.03 s) (Table 1). 
Table 1. Effects of the ethanol extract from A. muricata leaves on acetic acid-induced 
writhing in mice. 
Group  Dose (mg/kg)  Number of writhes  Inhibition (%) 
Control  Saline 67.62   2.03  - 
  100 67.50   1.74  - 
Ethanol Extract  200 57.87   1.55**  14.42 
  400 39.62   1.97***  41.41 
Indomethacin  10 18.25   0.80***  73.01 
Data are mean  s.e.m. of eight mice. **P < 0.01, ***P < 0.001 vs. control group. 
2.3. Effects on Formalin-Induced Nociception in Mice 
The intraplantar injection of formalin promoted a biphasic characteristic response (Table 2). The 
time spent licking in the first phase (0-5 min) was 86.62 ± 3.18 s and in the second phase (15-30 min) 
was 93.87 ± 2.73 s for the control group. After 60 min of treatment, doses (p.o.) of 200 and 400 mg/kg 
of extract significantly inhibited (p < 0.001) the first phase at 23.67 and 45.02% and the second phase 
at 30.09 and 50.20%, respectively, when compared to the control. 
Table 2. Effects of the ethanol extract from A. muricata leaves on formalin-induced 
nociception in mice. 
Group 
Dose 
(mg/kg) 
Duration of paw licking (s) 
First phase 
Inhibition 
(%) 
Second phase 
Inhibition 
(%) 
Control  Saline 86.62   3.18  -  93.87  2.73  - 
  100 85.87   2.88  -  91.25  3.07  - 
Ethanol 
Extract 
200 66.12   1.54***  23.67  65.62  1.72***  30.09 
  400 47.62   2.13***  45.02  46.75  1.68***  50.20 
Morphine  1 16.25   1.44***  81.24  19.37  0.94***  79.36 
First phase = 0–5 min after formalin injection; second phase = 15–30 min. 
Data are mean  s.e.m. of eight mice. ***P < 0.001 vs. control group. 
2.4. Effects on Hot-Plate Latency Assay in Mice 
The  A. muricata ethanol extract increased the latency time of mice exposed to the hot plate   
(Table 3). After 60 and 90 min of treatment, doses (p.o.) of 200 (30.77 and 37.04%) and 400 mg/kg 
(82.61 and 96.30%) increased significantly (p < 0.05 and p < 0.001, respectively) the latency time in 
the respective control group. Morphine proved to be a potent analgesic, increasing the latency time Int. J. Mol. Sci. 2010, 11                 
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within the evaluation periods. Naloxone, an opioid antagonist, blocked the morphine action but did not 
completely alter the antinociceptive effect of the tested extracts. 
Table 3. Effects of the ethanol extract from A. muricata leaves on the reaction time (s) of 
mice exposed to the hot-plate test. 
Group Dose 
(mg/kg) 
Time after drug administration (s) 
0 min  30 min  60 min  90 min 
Control Saline  5.50   0.80  6.12  0.44  6.50  0.50  6.75  0.79 
 100  5.37   0.80  6.25  0.62  7.12  0.29  7.25  0.45 
Ethanol Extract  200  5.50  0.78  6.75  0.45  8.50  0.50*  9.25  0.67* 
 400  5.75   0.72  7.37  0.80  11.87  0.64***  13.25  0.84***
Morphine 1  5.75   0.65  9.62  0.82**  13.75  1.10***  16.87  0.93***
Naloxone + Morphine  1 + 1  6.00  0.68  7.87  0.69  8.00  0.46*  7.87  0.55 
Naloxone + Extract  1 + 400  5.62  0.68  7.25  0.75  8.75  0,45**  10.87  0.83** 
Data are mean  s.e.m. of eight mice. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group. 
2.5. Effects on Carrageenan-induced Edema in Rats 
The  A. muricata ethanol extract anti-inflammatory effect evaluated by the paw edema method 
induced by carrageenan is shown in Table 4. Edema inhibition was observed 3 h after carrageenan 
application of doses (p.o.) of 200 (0.73  0.06; 23.16 %; p < 0.05) and 400 mg/kg (0.67  0.04;  
29.47 %; p < 0.01). 4 h after carrageenan injections, the doses of 200 (0.53  0.03; p < 0.01) and  
400 mg/kg (0.47  0.02; p < 0.001) reduced the respective paw edema (29.33 and 37.33%). In this 
time, indomethacin also reduced the paw edema (42.67%). 
Table 4. Effects of the ethanol extract from A. muricata leaves on carrageenan-induced 
paw edema in rats. 
Group 
Dose 
(mg/kg) 
Volume of hind paw (mL) 
1 h  2 h  3 h  4 h 
Control  Saline 0.53   0.06  0.72  0.05  0.95  0.06  0.75  0.06 
  100 0.52   0.09  0.68  0.06  0.80  0.06  0.63  0.04 
Ethanol Extract  200 0.50   0.10  0.65  0.09  0.73  0.06*  0.53  0.03** 
  400 0.48   0.07  0.60  0.04  0.67  0.04**  0.47  0.02*** 
Indomethacin  10 0.47   0.10  0.58  0.05  0.62  0.06**  0.43  0.02*** 
Data are mean  s.e.m. of six rats. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group. 
2.6. Effects on Carrageenan-Induced Pleurisy in Rats 
The pleurisy effects demonstrated that doses (p.o.) of 200 (p < 0.01) and 400 mg/kg (p < 0.001) of 
the extracts significantly reduced the exudate volume (Figure 1) and the number of total leukocytes 
(Figure 2). The exudate volume was decreased by 29.25 and 45.74% at doses (p.o.) of 200 and   
400 mg/kg compared to the respective control. Leukocyte migration inhibition also occurred from doses Int. J. Mol. Sci. 2010, 11                 
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(p.o.) of 200 (12.91  0.32  10
3 cells/mm
3; p < 0.001) and 400 mg/kg (11.37  0.44  10
3 cells/mm
3;  
p < 0.001). Indomethacin reduced the exudate volume and the leukocyte migration. 
Figure 1. Effects of the ethanol extract from A. muricata leaves on pleural exudation 
induced by carrageenan in rats. Data are mean  s.e.m. of six rats. **P  < 0.01,   
***P < 0.001 vs. control group. 
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Figure 2. Effects of the ethanol extract from A. muricata leaves on number of leucocytes 
in carrageenan-induced pleurisy in rats. Data are mean  s.e.m. of six rats. ***P < 0.001 
vs. control group. 
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The acute toxicity test showed that the A. muricata leaves ethanol extract doses tested were toxic to 
mice. However, the largest dose administered (400 mg/kg) is less than the lowest dose applied for 
determination of the LD50  (0.5 g/kg or 500 mg/kg). Studies have demonstrated that isolated 
acetogenins from the A. muricata leaves are toxic to tumor cells [11-17] and molluscicides [18]. It is 
possible that the toxic effect of the ethanol extract could be due to the presence of these substances. 
However, the pharmacological doses definition of the ethanol extract was not described in the 
literature. In the present study, the LD50 was used to define the doses that were administered to   
the animals.  
Based on the pharmacological tests results, the A. muricata ethanol extract has antinociceptive and 
anti-inflammatory activities, being firstly reported in the literature. Intraperitoneal administration of 
acetic acid releases prostaglandins and sympathomimetic system mediators like PGE2 and PGF2
 and 
their levels were increased in the peritoneal fluid of the acetic acid induced mice [21]. Thus, the 
antinociceptive effect of the ethanol extract could be mediated by peripherical effects, including the 
prostaglandin synthesis inhibition. The antinociceptive effect was also demonstrated by the biphasic 
response time of paw licking induced by formalin [22]. The first phase (0 to 5 min) corresponds to the 
neurogenic stage as an intensely painful process for the activation of nociceptive pathways, while 
inflammation mediators are produced after 15 minutes of formalin application (second phase) [22,23]. 
Substance P and bradykinin act as mediators in the first phase, while histamine, serotonin, 
prostaglandin and bradykinin are involved in the nociceptive response of the second stage [23]. The 
central action was confirmed in the hot plate test (200 and 400 mg/kg), showing that the maximum 
effect is reached after 90 minutes. This test is considered to be sensitive to drugs acting at the 
supraspinal modulation level of the pain response [24], suggesting at least a modulatory effect of the 
extract. In this study, antinociceptive action did not depend entirely on the opioid system, because 
naloxone treatment did not completely reverse the produced effect [25,26]. The formalin induced 
algesia test also indicated a possible anti-inflammatory activity (the second phase was reduced   
from 200 mg/kg).  
The anti-inflammatory activity was confirmed by the paw edema induced by carrageenan in rats, a 
model widely used to study anti-inflammatory substances. Carrageenan induces paw edema resulting 
in the release of mediators such as histamine, serotonin, bradykinin, substance P and a platelet 
activating factor and prostaglandins [27-33]. In this study, oral treatment with the A. muricata extract 
significantly inhibited the paw edema. This evidence suggests that the anti-inflammatory actions of the 
ethanol extract are related to inhibition of one or more signaling intracellular pathways involved with 
these mediators effects. 
Pleurisy produced by intrapleural injection of carrageenan leads to the formation of exudate in the 
pleural cavity [34,35] and leukocyte migration [35,36]. It is a method that assesses the inflammatory 
infiltrate and confirms the obtained paw edema results. Non-steroidal anti-inflammatory drugs, such as 
indomethacin, inhibit the accumulation of exudates and mobilization of leukocytes between 3 and 6 h 
after application of carrageenan [35,37]. By reducing the volume of exudate and the leukocyte 
migration, the A. muricata ethanol extract confirmed the results of the paw edema (Table 4 and   
Figures 1 and 2). 
Plants belonging to the Annonaceae family have been investigated for its antinociceptive and anti-
inflammatory properties [25,26,38]. However, considering the compounds isolated from A. muricata, Int. J. Mol. Sci. 2010, 11                 
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these properties are not been reported for the alkaloids [4,5] and acetogenins [8-18]. Antinociceptive 
and anti-inflammatory activities have been attributed to essential oil of Dennettia tripetala 
(Annonaceae) [38], but such activities are not described for the major components [6,7] identified in A. 
muricata. Additional studies are necessary to establish the possible correlation between activities and 
chemical composition of this plant.  
3. Experimental Section 
3.1. Plant Material and Extraction 
The plant material used in this study was collected in Juiz de Fora, State of Minas Gerais, Brazil, in 
February 2008. The species was identified by Dr Fátima Regina Gonçalves Salimena and a voucher 
specimen (CESJ number 48236) was deposited in the Herbarium of the Universidade Federal de Juiz 
de Fora, Brazil. Dried and powdered leaves (600 g) were exhaustively extracted in 95% ethanol   
(2.5 L) by static maceration for 3 weeks at room temperature with renewal of solvent every 2 days. 
The ethanol extract was filtered and evaporated under a rotary evaporator at controlled temperature 
(50-60 °C). This material was placed in a desiccator with silica to yield 36.40 g. The dried extract was 
dissolved using 1% DMSO in normal saline for pharmacological studies. 
3.2. Chemicals 
Drugs and reagents used in this study (and their sources) were as follows: acetic acid (Vetec 
Química Farm Ltda, Rio de Janeiro, RJ, Brazil), formaldehyde (Reagen Quimibrás Ind. Química S.A., 
Rio de Janeiro, RJ, Brazil), morphine hydrochloride (Merck Inc., Whitehouse Station, NJ, USA), 
naloxone and indomethacin (Sigma Chemical Co, St Louis, MI, USA). 
3.3. Animals 
Male Wistar rats (90-110 days) weighing 200-240 g and male Swiss albino mice (50-70 days) 
weighing 25-30 g were used in the experiments. The animals were provided by the Central Biotery of 
the Universidade Federal de Juiz de Fora. The animals were divided into groups and kept in plastic 
cages (47  34  18 cm) under a 12 h light/12 h dark cycle at room temperature (22  2 °C), with free 
access to Purina rations and water. Animal care and the experimental protocol followed the principles 
and guidelines suggested by the Brazilian College of Animal Experimentation (COBEA) and were 
approved by the local ethical committee. 
3.4. Acute Toxicity 
Groups of ten mice received oral doses of 0.5, 1, 1.5, 2 and 3 g/kg of ethanol extract from A. 
muricata, while the control group received the vehicle (saline). The groups were observed for 48 h and 
mortality at end of this period was recorded for each group [39]. The LD50 (50% lethal dose) was 
determined by probit test using a log plot of percentage death versus dose [40]. The determination of 
LD50 served to define the doses used in experiments of pharmacological activities. 
 Int. J. Mol. Sci. 2010, 11                 
 
 
2074
3.5. Acetic Acid-Induced Writhing Response in Mice 
Antinociceptive activity was evaluated using the test of abdominal writhing induced by acetic acid 
in mice [41]. Animals were divided into groups of eight mice. Control mice received an i.p. injection 
of acetic acid 0.6% (0.25 mL) and 10 min later the writhes were counted over a period of 20 min. One 
group of mice received indomethacin (10 mg/kg) by the per oral route (p.o.) as a reference compound, 
and the other three groups received the extract at doses (p.o.) of 100, 200 and 400 mg/kg, 1 h before 
the acetic acid injection. 
3.6. Formalin-Induced Nociception in Mice 
Mice received subplantar injections of 20 L 2.5% formalin (in 0.9% saline) and the time of paw 
licking (in seconds) was determined over 0-5 min (first phase - neurogenic) and 15-30 min (second 
phase - inflammatory) after formalin injection [22]. Animals (n = 8) were pretreated p.o. with extract 
(100, 200 or 400 mg/kg; 0.1 mL per 10 g body weight) or the reference compound, subcutaneous 
morphine (1 mg/kg), 1 h before administration of formalin. Control animals were treated with sterile 
saline (10 mL/kg). 
3.7. Hot-Plate Latency Assay in Mice 
Animals were placed on a hot-plate (Model LE 7406, Letica Scientific Instruments, Barcelona, 
Spain) heated at 55  1 °C [42]. Three groups of mice (n = 8) were treated p.o. with ethanol extract 
(100, 200 or 400 mg/kg; 0.1 mL per 10 g body weight); the control group received sterile saline  
(10 mL/kg). Measurements were performed at time 0, 30, 60 and 90 min after drug administration, 
with a cut-off time of 40 s to avoid lesions to the animals’ paws. The effect of pretreatment with 
naloxone (1 mg/kg, subcutaneously) on the analgesia produced by the ethanol extract (400 mg/kg) was 
determined in a separate group of animals. Morphine (1 mg/kg, subcutaneously), in the absence and 
presence of naloxone treatment, was used as a reference. 
3.8. Carrageenan-Induced Edema in Rats 
Anti-inflammatory activity was assessed on the basis of inhibition of paw edema induced by the 
injection of 0.1 mL of 2% carrageenan (an edematogenic agent) into the subplantar region of the right 
hind paw of the rat [43]. Male Wistar rats were divided into groups of six animals which received p.o. 
doses of extract (100, 200 and 400 mg/kg; 0.1 mL per 10 g body weight), saline or indomethacin  
(10 mg/kg) 1 h before the injection of carrageenan. In the left paw, used as a control, 0.1 mL of sterile 
saline was injected. 1, 2, 3 and 4 h after injection of carrageenan, the measure of edema was made by 
the difference between the volume displaced by the right paw and the left paw using a plethysmometer 
(model LE 7500, Letica Scientific Instruments, Barcelona, Spain). 
3.9. Carrageenan-Induced Pleurisy in Rats 
Pleurisy was induced in male Wistar rats by intrapleural administration of 0.5 mL 2% carrageenan 
suspension in saline solution between the third and fifth ribs on the right side of the mediastinum [37]. Int. J. Mol. Sci. 2010, 11                 
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Extract (100, 200 and 400 mg/kg), saline or indomethacin (10 mg/kg) p.o. were given 60 min before 
injection of the irritant. Animals were killed 4 h after carrageenan injection, and the skin and pectoral 
muscles were retracted. A longitudinal incision was made between the third and fifth ribs on each side 
of the mediastinum. The exudate was collected and transferred to a 15 mL conical centrifuge tube and 
the total volume determined. A 50 L aliquot of the exudate was used to determine the total leucocyte 
count in Neubauer chambers. 
3.10. Calculations and Statistical Analysis 
Data are expressed as mean  s.e.m. Statistical significance was determined by one-way analysis of 
variance followed by the Student–Newman–Keuls test. P values below 0.05 were considered 
significant. The percentage of inhibition was calculated by using  
100 − T  100/C(%) or T  100/C − 100(%) 
where C and T indicate non-treated (vehicle) and drug-treated, respectively. 
4. Conclusions 
The results obtained in this study confirm the ethnomedicinal use of the ethanol extract from   
A. muricata leaves. The data analysis supported the antinociceptive and anti-inflammatory activities, 
suggesting a potential for therapeutic purposes. However, further studies should be conducted to 
ensure its safe usage. 
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